Viral hepatitis

Last updated: February 22, 2023

Viral hepatitis

D115

D115

Systemic lupus erythematosus
Turner syndrome
Klinefelter syndrome
Fragile X syndrome
Prader-Willi syndrome
Angelman syndrome
Endocrine system anatomy and physiology
Restrictive lung diseases
Down syndrome (Trisomy 21)
Pyloric stenosis
Innate immune system
Antibody classes
HIV (AIDS)
Myasthenia gravis
Meningitis
Multiple sclerosis
Guillain-Barre syndrome
Delirium
Dementia with Lewy bodies
Alzheimer disease
Seizures and epilepsy
Normal pressure hydrocephalus
Huntington disease
Parkinson disease
Concussion and traumatic brain injury
Lambert-Eaton myasthenic syndrome
Major depressive disorder
Generalized anxiety disorder
Schizophrenia
Spina bifida
Phenylketonuria (NORD)
Tay-Sachs disease (NORD)
Cerebral palsy
Hyperparathyroidism
Hypoparathyroidism
Diabetes insipidus
Graves disease
Diabetes mellitus
Cushing syndrome
Primary adrenal insufficiency
Breast cancer
Benign prostatic hyperplasia
Ovarian cyst
Pneumonia
Chronic bronchitis
Asthma
Emphysema
Pulmonary embolism
Pneumothorax
Pleural effusion
Bronchiectasis
Acute respiratory distress syndrome
Mycobacterium tuberculosis (Tuberculosis)
Cor pulmonale
Bacterial epiglottitis
Laryngomalacia
Respiratory syncytial virus
Cystic fibrosis
Sudden infant death syndrome
Disseminated intravascular coagulation
Sickle cell disease (NORD)
Chronic leukemia
Acute leukemia
Myocardial infarction
Deep vein thrombosis
Hypoplastic left heart syndrome
Angina pectoris
Aortic dissection
Aortic dissections and aneurysms: Pathology review
Iron deficiency anemia
Aplastic anemia
Autoimmune hemolytic anemia
Polycythemia vera (NORD)
Immune thrombocytopenia
Epstein-Barr virus (Infectious mononucleosis)
Non-Hodgkin lymphoma
Hodgkin lymphoma
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Beta-thalassemia
Alpha-thalassemia
Raynaud phenomenon
Arterial disease
Peripheral artery disease
Coronary artery disease: Pathology review
Pericarditis and pericardial effusion
Rheumatic heart disease
Heart failure
Patent ductus arteriosus
Ventricular septal defect
Pulmonary valve disease
Kawasaki disease
Tetralogy of Fallot
Urinary tract infections: Clinical
Kidney stones
Chronic kidney disease
Nephrotic syndromes: Pathology review
Acute pyelonephritis
Chronic pyelonephritis
Lower urinary tract infection
Neurogenic bladder
Bladder exstrophy
Hypospadias and epispadias
Polycystic kidney disease
Hemolytic-uremic syndrome
Nephroblastoma (Wilms tumor)
Vesicoureteral reflux
Renal failure: Pathology review
Gastrointestinal bleeding: Pathology review
Gastroesophageal reflux disease (GERD)
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Zollinger-Ellison syndrome
Wilson disease
Malabsorption syndromes: Pathology review
Ulcerative colitis
Crohn disease
Irritable bowel syndrome
Diverticulosis and diverticulitis
Appendicitis
Portal hypertension
Intussusception
Celiac disease
Gastric cancer
Acute pancreatitis
Chronic pancreatitis
Chronic cholecystitis
Acute cholecystitis
Gallstones
Jaundice
Viral hepatitis
Hepatitis A and Hepatitis E virus
Hepatitis B and Hepatitis D virus
Hepatitis C virus
Cirrhosis
Biliary atresia
Hirschsprung disease
Paget disease of bone
Osteoporosis
Osteoarthritis
Atopic dermatitis
Varicella zoster virus
Osteomalacia and rickets
Bone tumors
Rheumatoid arthritis
Ankylosing spondylitis
Gout
Fibromyalgia
Hypothyroidism
Hypomagnesemia
Glycogen storage disorders: Pathology review
Glycogen storage disease type II (NORD)
Myalgias and myositis: Pathology review
Polymyositis
Dermatomyositis
Lordosis, kyphosis, and scoliosis
Osgood-Schlatter disease (traction apophysitis)
Legg-Calve-Perthes disease
Muscular dystrophy
Scleroderma
Psoriasis
Lichen planus
Pemphigus vulgaris
Acne vulgaris
Erythema multiforme
Stevens-Johnson syndrome
Lyme Disease
Herpes simplex virus
Skin cancer
Human herpesvirus 8 (Kaposi sarcoma)
Rubella virus
Measles virus
Burns
Shock
Cri du chat syndrome
Prostate cancer
Post-traumatic stress disorder
Wiskott-Aldrich syndrome
Ataxia-telangiectasia
DiGeorge syndrome
Persistent truncus arteriosus
Membranoproliferative glomerulonephritis
Poststreptococcal glomerulonephritis
Menstrual cycle

Transcript

Watch video only

Content Reviewers

Hepatitis, meaning like this inflammation, of the liver, most commonly comes about because of a virus.

These viruses tend to target the cells in the liver, and when they get in and infect these cells, they tend to cause them to present these weird and abnormal proteins via their MHC class 1 molecules, and at the same time, you’ve also got these immune cells infiltrating the liver and trying to figure out what’s going on, and so the CD8 positive T cells recognize these abnormal proteins as a sign that the cells are pretty much toast, and the hepatocytes go through cytotoxic killing by the T cells and apoptosis.

Hepatocytes undergoing apoptosis are sometimes referred to as Councilman bodies, shown on histology here, and this typically takes place in the portal tracts and lobules of the liver.

This cytotoxic killing of hepatocytes is the main mechanism behind inflammation of the liver, and eventual liver damage in viral hepatitis!

As someone’s hepatitis progresses, we’ll see a couple classic symptoms related to your immune system mounting an attack, like fever, malaise, and nausea.

Additionally though, patients might have hepatomegaly, where their liver is abnormally large from inflammation, which might cause some pain.

Also, as more and more damage is done to the liver, the amount of transaminases in their blood will increase.

Your liver has these transaminase enzymes so it can do its job of breaking down various amino acids.

Typically the serum amino transaminase, or the amount in your blood, is pretty low, but when your hepatocytes start getting damaged they start leaking these into the blood, so a common sign is a greater amount of both alanine aminotransferase, or ALT, and aspartate aminotransferase, or AST, typically even though both are elevated, ALT will be greater than AST in viral hepatitis and will also be the last of the two liver enzymes to return to normal.

Also, elevated levels of atypical lymphocytes are common to see with viral hepatitis, known as atypical lymphocytosis.

The lymphocytes are usually like huge, very large, due to stimulation from antigens, in our case the hepatitis virus antigens.

Patients often also end up developing jaundice, with a mix of both conjugated bilirubin and unconjugated bilirubin.

The conjugated bilirubin leaks out when bile ductules are damaged or destroyed when the hepatocytes die, which make up some of its lining!

Also, since these hepatocytes are dying, you start to lose the ability to conjugate bilirubin and make it water soluble, and so you also end up with unconjugated bilirubin as well.

So since there’s both conjugated and unconjugated bilirubin in the blood, some of the water soluble conjugated bilirubin gets filtered into the urine, giving it a darker color.

If symptoms continue or the virus sticks around for more than 6 months, viral hepatitis goes from being called acute to being called chronic hepatitis.

At this point, inflammation mostly happens in the portal tract, and if inflammation and fibrosis keep persisting, we consider that a bad sign, since it might be progressing to postnecrotic cirrhosis.

When things progress to cirrhosis, there may also be increased urobilinogen in the urine.

Normally, urobilinogen is made by intestinal microbes that convert the bilirubin in bile to urobilinogen.

And usually, most of the urobilinogen is reabsorbed from the intestine and goes back to the liver, where it’s converted back to bilirubin.

However, with cirrhosis, liver cells aren’t working properly anymore, so there’s a lot of liver fibrosis, so hepatocytes can’t process the urobilinogen, which is redirected to the kidneys and excreted, so you end up with more urobilinogen in your urine.

Now there are five known flavors or types of hepatitis virus, that have slightly different and unique properties.

Hepatitis A is transmitted through ingestion of contaminated food or water, in other words the fecal-oral route, and is known to be acquired by travelers.

Hepatitis A virus, or HAV, is almost always acute only, and there is essentially no chronic HAV.

If we’re talking serological markers, an HAV-IgM antibody indicates an active infection, whereas HAV-IgG antibody is a protective antibody and tells us that there’s been recovery from HAV or vaccination in the past.

Hepatitis E virus’s actually pretty similar to HAV, with the same route of transmission, oral-fecal, and is most commonly acquired through undercooked seafood or contaminated water.

It also doesn’t have much of a chronic state, and HEV-IgM antibodies tell us there’s an active infection and HEV-IgG antibody is protective and signals recovery.

Two big differences to note though between these two guys, is that (1) only HAV has the option for immunization and (2) HEV infection for pregnant women can be very serious, and can lead to acute liver failure, also sometimes called fulminant hepatitis.

Alright next on the docket is Hepatis C virus, this guy is transmitted via the blood, so could be from childbirth, intravenous drug abuse, and there’s also a small chance of getting it through unprotected sex, if there are open lesions, like cuts or sores, in the genital area.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Hepatitis viruses: Not always what it seems to be" Revista médica de Chile (2010)
  6. "Viral hepatitis and liver cancer" Philosophical Transactions of the Royal Society B: Biological Sciences (2017)